SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?


To: J Stone who wrote (28513)3/11/1999 3:21:00 PM
From: notyet  Respond to of 32384
 
Info

equity.freerealtime.com



To: J Stone who wrote (28513)3/11/1999 4:39:00 PM
From: Henry Niman  Read Replies (2) | Respond to of 32384
 
Yes, All of the CTCL patients responded to treatment with the higher dose of Targretin. The response range from stabilization of the disease to complete remission:

prnewswire.com